The TRI Foundation (formerly PA Research Foundation) has a proud history of funding innovative medical research at the PA Hospital Campus. From providing seed funding to the discovery of the world's first cancer vaccine, to funding a world first clinical trial in a new combination therapy for aggressive cancers such as triple negative breast cancer and head and neck cancer, we are invested in making a difference on a global scale.
Our new Translational Research Innovation Awards have been established to allow us to take a more donor directed approach in the distribution of grants; our donors want to fund the most innovative and ground-breaking research leading to improved patient care in preferred areas, our new Awards help facilitate this.
Through our new Awards, we will continue to invest in research that is innovative, novel and will give us the best opportunity of supporting the next big medical discovery or transformational health care project.
Our funded areas are Breast Cancer, Prostate Cancer, Skin Cancer, Other Cancer Areas and Other Health Areas.
Areas of Research
Breast CancerThe TRI Foundation is wholeheartedly committed to funding breast cancer research at the PA Campus. Our nationwide Project Pink campaign has raised over $2.5 million over the past eight years thanks to the support of our valued corporate partners and their communities who have fundraised for the cause.
Skin cancer is a disease of the body's skin cells which occurs when skin cells are damaged. This damage is usually caused by overexposure to ultraviolet (UV) radiation from the sun where the cells change or mutate to form skin cancer.
Other Cancer Areas
The TRI Foundation support cancer research in a number of different fields including head and neck cancer.
Other Health Areas
Along with many types of cancer the TRI Foundation support research in significant life debilitating diseases.